The Pre-Symptomatic Space with Patrick Short, Sano Genetics

Patrick Short, CEO of Sano Genetics, discusses overcoming challenges in genetic research, emphasizing accessibility and pre-symptomatic treatments for conditions like ALS. They also explore early detection strategies using biomarkers for diseases like Alzheimer's and Braca mutations.